Related references
Note: Only part of the references are listed.Cdk-inhibitory activity and stability of p27Kip1 are directly regulated by oncogenic tyrosine kinases
Matthias Grimmler et al.
CELL (2007)
Src kinase signaling in leukaemia
Shaoguang Li
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2007)
Characterization of murine JAK2V617F-positive myeloproliferative disease
Thomas G. P. Bumm et al.
CANCER RESEARCH (2006)
Prognostic role of p27Kip1 deregulation in colorectal cancer
Dan D. Hershko et al.
CANCER (2006)
Expression of Jak2V617F causes a polycythemia vera-like disease with associated myelofibrosis in a murine bone marrow transplant model
Gerlinde Wernig et al.
BLOOD (2006)
Structural basis of the Cks1-dependent recognition of p27Kip1 by the SCFSkp2 ubipuitin ligase
B Hao et al.
MOLECULAR CELL (2005)
Ubiquitination of p27Kip1 requires physical interaction with cyclin E and probable phosphate recognition by SKP2
D Ungermannova et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
RNAi-induced down-regulation of FLT3 expression in AML cell lines increases sensitivity to MLN518
DK Walters et al.
BLOOD (2005)
Requirement of Src kinases Lyn, Hck and Fgr for BCR-ABL1-induced B-lymphoblastic leukemia but not chronic myeloid leukemia
YG Hu et al.
NATURE GENETICS (2004)
Alterations in the expression of the cell cycle regulatory protein cyclin kinase subunit 1 in colorectal carcinoma -: Relation to p27Kip1 and its ubiquitin ligase subunit, S phase kinase protein 2
M Shapira et al.
CANCER (2004)
Role of Cks1 overexpression in oral squamous cell carcinomas - Cooperation with Skp2 in promoting p27 degradation
S Kitajima et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Cytoplasmic ubiquitin ligase KPC regulates proteolysis of p27Kip1 at G1 phase
T Kamura et al.
NATURE CELL BIOLOGY (2004)
Inhibition of wild-type and mutant Bcr-Abl by AP23464, a potent ATP-based oncogenic protein kinase inhibitor: implications for CML
T O'Hare et al.
BLOOD (2004)
Critical role for hematopoietic cell kinase (Hck)-mediated phosphorylation of Gab1 and Gab2 docking proteins in interleukin 6-induced proliferation and survival of multiple myeloma cells
K Podar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Normal and leukemic hematopoiesis:: Are leukemias a stem cell disorder or a reacquisition of stem cell characteristics?
E Passegué et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Autoinhibition of Bcr-Abl through its SH3 domain
KM Smith et al.
MOLECULAR CELL (2003)
Chronic myelogenous leukemia as a paradigm of early cancer and possible curative strategies
B Clarkson et al.
LEUKEMIA (2003)
A member of forkhead transcription factor FKHRL1 is a downstream effector of STI571-induced cell cycle arrest in BCR-ABL-expressing cells
N Komatsu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Expression of Skp2, a p27Kip1 ubliquitin ligase, in malignant lymphoma:: correlation with p27Kip1 and proliferation index
MS Lim et al.
BLOOD (2002)
Analysis of the structural basis of specificity of inhibition of the Abl kinase by STI571
AS Corbin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
In vitro studies of the combination of imatinib mesylate (Gleevec) and arsenic trioxide (Trisenox) in chronic myelogenous leukemia
P La Rosée et al.
EXPERIMENTAL HEMATOLOGY (2002)
The Tel-Abl (ETV6-Abl) tyrosine kinase, product of complex (9;12) translocations in human leukemia, induces distinct myeloproliferative disease in mice
RP Million et al.
BLOOD (2002)
Flk-2 is a marker in hematopoietic stem cell differentiation: A simple method to isolate long-term stem cells
JL Christensen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
BCR-ABL and interleukin 3 promote haematopoietic cell proliferation and survival through modulation of cyclin D2 and p27Kip1 expression
Y Parada et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
TGFβ-induced SMAD2 phosphorylation predicts inhibition of thymidine incorporation in CD34+ cells from healthy donors, but not from patients with AML after MDS
S Koschmieder et al.
LEUKEMIA (2001)
Skp2 is oncogenic and overexpressed in human cancers
M Gstaiger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Role of the F-box protein Skp2 in lymphomagenesis
E Latres et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
The Src homology 2 domain of Bcr/Abl is required for efficient induction of chronic myeloid leukemia-like disease in mice but not for lymphoid leukemogenesis or activation of phosphatidylinositol 3-kinase
S Roumiantsev et al.
BLOOD (2001)
Abnormal integrin-mediated regulation of chronic myelogenous leukemia CD34+ cell proliferation:: BCR/ABL up-regulates the cyclin-dependent kinase inhibitor, p27Kip, which is relocated to the cell cytoplasm and incapable of regulating cdk2 activity
YH Jiang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Targeted disruption of Skp2 results in accumulation of cyclin E and p27Kip1, polyploidy and centrosome overduplication
K Nakayama et al.
EMBO JOURNAL (2000)
Share Paper
